BKYI
BIO-key International, Inc. (BKYI) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Industrials sector peers. Its strongest pillar is Growth (B+); its weakest is Momentum (D+). The rating has held at C+ for 6 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-17 | B (3.5) | B+ (3.5) | B- (3.0) | D+ (1.5) | C (2.3) | C+ (2.8) |
| 2026-11-10 | B (3.4) | B+ (3.5) | B- (3.0) | D- (0.9) | C (2.3) | C+ (2.6) |
| 2026-11-03 | B (3.4) | B+ (3.5) | B- (3.0) | D- (0.9) | C (2.3) | C+ (2.6) |
| 2026-10-27 | B (3.3) | B+ (3.5) | B- (3.0) | D- (0.9) | C (2.2) | C+ (2.6) |
| 2026-10-20 | B (3.4) | B+ (3.5) | B- (3.0) | F (0.6) | C (2.2) | C+ (2.6) |